Vertinull 16 Mg
Vertinull® 16 mg Film-coated Tablets BP
Composition
Each film-coated tablet contains:
Betahistine Dihydrochloride BP…16 mg
Excipients………q.s.
Betahistine Dihydrochloride BP…16 mg
Excipients………q.s.
THERAPEUTIC INDICATIONS
Vertinull® 16 mg Film-coated Tablets BP is indicated for the treatment of Ménière’s disease defined by three symptoms: dizziness (with nausea and vomit), hearing loss, tinnitus.
DOSAGE
Adults: 24-48 mg/day divided in 3 intakes. Individually adjust according to the response.
PRESENTATIONS
Carton containing 30 film-coated tablets in blister pack.